SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Remco Dijk, Andreas E. Kremer, Wouter Smit, Bram Elzen, Thomas Gulik, Dirk Gouma, Johan S. Lameris, Hennie Bikker, Valentine Enemuo, Pieter C. F. Stokkers, Mark Feist, Piter Bosma, Peter L. M. Jansen, Ulrich Beuers, Characterization and treatment of persistent hepatocellular secretory failure, Liver International, 2014, 34, 10
  2. 2
    Lin Ding, Shuguang Pang, Yongmei Sun, Yuling Tian, Li Yu, Ningning Dang, Coordinated Actions of FXR and LXR in Metabolism: From Pathogenesis to Pharmacological Targets for Type 2 Diabetes, International Journal of Endocrinology, 2014, 2014, 1

    CrossRef

  3. 3
    Carolien Out, Arne Dikkers, Anke Laskewitz, Renze Boverhof, Claude van der Ley, Ido P. Kema, Henk Wolters, Rick Havinga, Henkjan J. Verkade, Folkert Kuipers, Uwe J.F. Tietge, Albert K. Groen, Prednisolone increases enterohepatic cycling of bile acids by induction of Asbt and promotes reverse cholesterol transport, Journal of Hepatology, 2014, 61, 2, 351

    CrossRef

  4. 4
    Antimo Gioiello, Bruno Cerra, Wujuan Zhang, Gian Paolo Vallerini, Gabriele Costantino, Francesca De Franco, Daniela Passeri, Roberto Pellicciari, Kenneth D.R. Setchell, Synthesis of atypical bile acids for use as investigative tools for the genetic defect of 3β-hydroxy-Δ5-C27-steroid oxidoreductase deficiency, The Journal of Steroid Biochemistry and Molecular Biology, 2014, 144, 348

    CrossRef

  5. 5
    Egon Demetz, Andrea Schroll, Kristina Auer, Christiane Heim, Josef R. Patsch, Philipp Eller, Markus Theurl, Igor Theurl, Milan Theurl, Markus Seifert, Daniela Lener, Ursula Stanzl, David Haschka, Malte Asshoff, Stefanie Dichtl, Manfred Nairz, Eva Huber, Martin Stadlinger, Alexander R. Moschen, Xiaorong Li, Petra Pallweber, Hubert Scharnagl, Tatjana Stojakovic, Winfried März, Marcus E. Kleber, Katia Garlaschelli, Patrizia Uboldi, Alberico L. Catapano, Frans Stellaard, Mats Rudling, Keiji Kuba, Yumiko Imai, Makoto Arita, John D. Schuetz, Peter P. Pramstaller, Uwe J.F. Tietge, Michael Trauner, Giuseppe D. Norata, Thierry Claudel, Andrew A. Hicks, Guenter Weiss, Ivan Tancevski, The Arachidonic Acid Metabolome Serves as a Conserved Regulator of Cholesterol Metabolism, Cell Metabolism, 2014, 20, 5, 787

    CrossRef

  6. 6
    Amber R. Tompsett, Eric Higley, Sara Pryce, John P. Giesy, Markus Hecker, Steve Wiseman, Transcriptional changes in African clawed frogs (Xenopus laevis) exposed to 17α-ethynylestradiol during early development, Ecotoxicology, 2014,

    CrossRef

  7. 7
    J. Chiang, Pathobiology of Human Disease, 2014,

    CrossRef

  8. 8
    Tatsuo Inamine, Shingo Higa, Fumie Noguchi, Shinji Kondo, Katsuhisa Omagari, Hiroshi Yatsuhashi, Kazuhiro Tsukamoto, Minoru Nakamura, Association of genes involved in bile acid synthesis with the progression of primary biliary cirrhosis in Japanese patients, Journal of Gastroenterology, 2013, 48, 10, 1160

    CrossRef

  9. 9
    Emina Halilbasic, Thierry Claudel, Michael Trauner, Bile acid transporters and regulatory nuclear receptors in the liver and beyond, Journal of Hepatology, 2013, 58, 1, 155

    CrossRef

  10. 10
    Anne S. Kienhuis, Alexa P. Vitins, Jeroen L.A. Pennings, Tessa E. Pronk, Ewoud N. Speksnijder, Marianne Roodbergen, Joost H.M. van Delft, Mirjam Luijten, Leo T.M. van der Ven, Cyclosporine A treated in vitro models induce cholestasis response through comparison of phenotype-directed gene expression analysis of in vivo Cyclosporine A-induced cholestasis, Toxicology Letters, 2013, 221, 3, 225

    CrossRef

  11. 11
    Alaa El-Sisi, Sahar Hegazy, Eman El-Khateeb, Effects of Three Different Fibrates on Intrahepatic Cholestasis Experimentally Induced in Rats, PPAR Research, 2013, 2013, 1

    CrossRef

  12. 12
    Dong Wook Kang, Hans F. Luecke, Facile Synthetic Routes to Prepare α-Muricholic Acid, Hyocholic Acid, and Their Taurine Conjugates, Bulletin of the Korean Chemical Society, 2013, 34, 8, 2436

    CrossRef

  13. 13
    James H Tabibian, Keith D Lindor, Primary sclerosing cholangitis: a review and update on therapeutic developments, Expert Review of Gastroenterology & Hepatology, 2013, 7, 2, 103

    CrossRef

  14. 14
    Caroline S. Stokes, Dietrich A. Volmer, Frank Grünhage, Frank Lammert, Vitamin D in chronic liver disease, Liver International, 2013, 33, 3
  15. 15
    L.Maillette de Buy Wenniger, T. Pusl, U. Beuers, Encyclopedia of Biological Chemistry, 2013,

    CrossRef

  16. 16
    Karin Dilger, Simon Hohenester, Ursula Winkler-Budenhofer, Barbara A.J. Bastiaansen, Frank G. Schaap, Christian Rust, Ulrich Beuers, Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health, Journal of Hepatology, 2012, 57, 1, 133

    CrossRef

  17. 17
    Karl Walter Bock, Human UDP-glucuronosyltransferases: Feedback loops between substrates and ligands of their transcription factors, Biochemical Pharmacology, 2012, 84, 8, 1000

    CrossRef

  18. 18
    Magd A. Kotb, Molecular Mechanisms of Ursodeoxycholic Acid Toxicity, International Journal of Molecular Sciences, 2012, 13, 12, 8882

    CrossRef

  19. 19
    Keith D Lindor, Farnesoid X receptor agonists for primary biliary cirrhosis, Current Opinion in Gastroenterology, 2011, 27, 3, 285

    CrossRef

  20. 20
    Keita Terui, Takeshi Saito, Tomoro Hishiki, Yoshiharu Sato, Tetsuya Mitsunaga, Hideo Yoshida, Hepatic expression of multidrug resistance protein 2 in biliary atresia, Comparative Hepatology, 2011, 10, 1, 6

    CrossRef

  21. 21
    Tadeja Rezen, Damjana Rozman, Jean-Marc Pascussi, Katalin Monostory, Interplay between cholesterol and drug metabolism, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2011, 1814, 1, 146

    CrossRef

  22. 22
    Adam J. Rose, Mauricio Berriel Díaz, Anja Reimann, Johanna Klement, Tessa Walcher, Anja Krones-Herzig, Oliver Strobel, Jens Werner, Achim Peters, Anna Kleyman, Jan P. Tuckermann, Alexandros Vegiopoulos, Stephan Herzig, Molecular Control of Systemic Bile Acid Homeostasis by the Liver Glucocorticoid Receptor, Cell Metabolism, 2011, 14, 1, 123

    CrossRef

  23. 23
    Michel Fausther, Jonathan A. Dranoff, New insights on the pathogenesis of biliary cirrhosis provided by studies in FXR knockout mice, Journal of Hepatology, 2011, 55, 4, 939

    CrossRef

  24. 24
    Gabriela Kolouchova, Eva Brcakova, Petra Hirsova, Ludek Sispera, Pavel Tomsik, Jolana Cermanova, Radek Hyspler, Martina Slanarova, Leos Fuksa, Halka Lotkova, Stanislav Micuda, Pravastatin modulates liver bile acid and cholesterol homeostasis in rats with chronic cholestasis, Journal of Gastroenterology and Hepatology, 2011, 26, 10
  25. 25
    Richard J. Whitby, Jozef Stec, Raymond D. Blind, Sally Dixon, Lisa M. Leesnitzer, Lisa A. Orband-Miller, Shawn P. Williams, Timothy M. Willson, Robert Xu, William J. Zuercher, Fang Cai, Holly A. Ingraham, Small Molecule Agonists of the Orphan Nuclear Receptors Steroidogenic Factor-1 (SF-1, NR5A1) and Liver Receptor Homologue-1 (LRH-1, NR5A2), Journal of Medicinal Chemistry, 2011, 54, 7, 2266

    CrossRef

  26. 26
    Michael Trauner, Anna Baghdasaryan, Thierry Claudel, Peter Fickert, Emina Halilbasic, Tarek Moustafa, Gernot Zollner, Targeting Nuclear Bile Acid Receptors for Liver Disease, Digestive Diseases, 2011, 29, 1, 98

    CrossRef

  27. 27
    Tadeja Režen, The impact of cholesterol and its metabolites on drug metabolism, Expert Opinion on Drug Metabolism & Toxicology, 2011, 7, 4, 387

    CrossRef

  28. 28
    Muhammad Farooq, Richard J. Weaver, Colin J. Henderson, Gabrielle M. Hawksworth, Transcriptional regulation of the rat Ntcp and Bsep by PXR and FXR in vivo, Toxicology, 2011, 290, 2-3, 128

    CrossRef

  29. 29
    Lucas Maillette de Buy Wenniger, Ulrich Beuers, Bile salts and cholestasis, Digestive and Liver Disease, 2010, 42, 6, 409

    CrossRef

  30. 30
    Wendy L. van der Woerd, Saskia W.C. van Mil, Janneke M. Stapelbroek, Leo W.J. Klomp, Stan F.J. van de Graaf, Roderick H.J. Houwen, Familial cholestasis: Progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy, Best Practice & Research Clinical Gastroenterology, 2010, 24, 5, 541

    CrossRef

  31. 31
    Janneke M. Stapelbroek, Karel J. van Erpecum, Leo W.J. Klomp, Roderick H.J. Houwen, Liver disease associated with canalicular transport defects: Current and future therapies, Journal of Hepatology, 2010, 52, 2, 258

    CrossRef

  32. 32
    Emmanuel Gonzales, Emmanuel Jacquemin, Mutation specific drug therapy for progressive familial or benign recurrent intrahepatic cholestasis: A new tool in a near future?, Journal of Hepatology, 2010, 53, 2, 385

    CrossRef

  33. 33
    Gernot Zollner, Martin Wagner, Michael Trauner, Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity, Pharmacology & Therapeutics, 2010, 126, 3, 228

    CrossRef

  34. 34
    M Arrese, S J Karpen, Nuclear Receptors, Inflammation, and Liver Disease: Insights for Cholestatic and Fatty Liver Diseases, Clinical Pharmacology & Therapeutics, 2010, 87, 4, 473

    CrossRef

  35. 35
    Gustav PAUMGARTNER, Pharmacotherapy of cholestatic liver diseases, Journal of Digestive Diseases, 2010, 11, 3
  36. 36
    Saul J. Karpen, Michael Trauner, The new therapeutic frontier – Nuclear receptors and the liver, Journal of Hepatology, 2010, 52, 3, 455

    CrossRef

  37. 37
    M. Penza, M. Jeremic, C. Montani, M. Unkila, L. Caimi, G. Mazzoleni, Diego Di Lorenzo, Alternatives to animal experimentation for hormonal compounds research, Genes & Nutrition, 2009, 4, 3, 165

    CrossRef

  38. 38
    Maria-Angeles Aller, Jorge-Luis Arias, Isabel Prieto, Manuel Losada, Jaime Arias, Bile duct ligation: step-by-step to cholangiocyte inflammatory tumorigenesis, European Journal of Gastroenterology & Hepatology, 2009, 1

    CrossRef

  39. 39
    D. A. H. ELFAKI, E. BJORNSSON, K. D. LINDOR, Review article: nuclear receptors and liver disease – current understanding and new therapeutic implications, Alimentary Pharmacology & Therapeutics, 2009, 30, 8
  40. 40
    Luciano Adorini, Vitamin D receptor polymorphisms in primary biliary cirrhosis: A functional connection?, Journal of Hepatology, 2009, 50, 6, 1071

    CrossRef

  41. 41
    John Y. L. Chiang, Bile Acid Metabolism and Signaling, Comprehensive Physiology,